The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Reid Perper since year 2005.
The trader's CIK number is 1162977.
At the time of this reporting, Reid Perper is the $RPTTTL of Nxstage Medical, Inc. .
(stock ticker symbol NXTM).
See this page for all insider trading activities at Nxstage Medical, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-05-17||NXTM||Nxstage Medical, Inc.||Option Ex||18,196||13.60||247,465|
|2017-03-10||NXTM||Nxstage Medical, Inc.||Option Ex||15,272||14.99||228,927|
|2016-05-25||NXTM||Nxstage Medical, Inc.||Option Ex||7,000||18.55||129,850|
|2015-11-10||NXTM||Nxstage Medical, Inc.||Option Ex||7,000||18.55||129,850|
|2015-03-17||NXTM||Nxstage Medical, Inc.||Option Ex||14,000||13.88||194,320|
|2013-12-11||NXTM||Nxstage Medical, Inc.||Option Ex||14,000||3.38||47,320|
|2013-03-05||NXTM||Nxstage Medical, Inc.||Option Ex||14,000||5.39||75,460|
|2012-05-24||NXTM||Nxstage Medical, Inc.||Option Ex||14,000||12.20||170,800|
|2011-09-14||NXTM||Nxstage Medical, Inc.||Sale||30,000||19.20||575,850|
|2011-08-29||NXTM||Nxstage Medical, Inc.||Sale||20,000||18.42||368,380|
|2011-08-30||NXTM||Nxstage Medical, Inc.||Sale||30,000||18.44||553,200|
|2011-08-31||NXTM||Nxstage Medical, Inc.||Sale||28,540||18.71||533,983|
|2011-05-25||NXTM||Nxstage Medical, Inc.||Option Ex||7,000||10.83||75,810|
|2011-05-06||NXTM||Nxstage Medical, Inc.||Option Ex||7,000||10.83||75,810|
|2010-07-27||NXTM||Nxstage Medical, Inc.||Option Ex||12,000||12.59||151,080|
|2010-07-27||NXTM||Nxstage Medical, Inc.||Sale||8,945||16.89||151,081|
|2005-10-27||NXTM||Nxstage Medical, Inc.||Buy||51,755||10.00||517,550|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reid Perper ($RPTTTL of Nxstage Medical, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.